These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19679662)

  • 1. Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases.
    Loiarro M; Gallo G; Fantò N; De Santis R; Carminati P; Ruggiero V; Sette C
    J Biol Chem; 2009 Oct; 284(41):28093-28103. PubMed ID: 19679662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis identifies residues crucial for homodimerization of myeloid differentiation factor 88 (MyD88) and for its function in immune cells.
    Loiarro M; Volpe E; Ruggiero V; Gallo G; Furlan R; Maiorino C; Battistini L; Sette C
    J Biol Chem; 2013 Oct; 288(42):30210-30222. PubMed ID: 24019529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenically active MYD88 mutations in human lymphoma.
    Ngo VN; Young RM; Schmitz R; Jhavar S; Xiao W; Lim KH; Kohlhammer H; Xu W; Yang Y; Zhao H; Shaffer AL; Romesser P; Wright G; Powell J; Rosenwald A; Muller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Staudt LM
    Nature; 2011 Feb; 470(7332):115-9. PubMed ID: 21179087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of optineurin as an interleukin-1 receptor-associated kinase 1-binding protein and its role in regulation of MyD88-dependent signaling.
    Tanishima M; Takashima S; Honda A; Yasuda D; Tanikawa T; Ishii S; MaruYama T
    J Biol Chem; 2017 Oct; 292(42):17250-17257. PubMed ID: 28882891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.
    Loiarro M; Capolunghi F; Fantò N; Gallo G; Campo S; Arseni B; Carsetti R; Carminati P; De Santis R; Ruggiero V; Sette C
    J Leukoc Biol; 2007 Oct; 82(4):801-10. PubMed ID: 17548806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling.
    Lin SC; Lo YC; Wu H
    Nature; 2010 Jun; 465(7300):885-90. PubMed ID: 20485341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
    Seltzer J; Moorad R; Schifano JM; Landis JT; Dittmer DP
    J Virol; 2020 May; 94(10):. PubMed ID: 32161170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of dysfunction of human variants of the IRAK4 kinase and a role for its kinase activity in interleukin-1 receptor signaling.
    De S; Karim F; Kiessu E; Cushing L; Lin LL; Ghandil P; Hoarau C; Casanova JL; Puel A; Rao VR
    J Biol Chem; 2018 Sep; 293(39):15208-15220. PubMed ID: 30115681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FADD negatively regulates lipopolysaccharide signaling by impairing interleukin-1 receptor-associated kinase 1-MyD88 interaction.
    Zhande R; Dauphinee SM; Thomas JA; Yamamoto M; Akira S; Karsan A
    Mol Cell Biol; 2007 Nov; 27(21):7394-404. PubMed ID: 17785432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and functional characterization of IRAK4 in large yellow croaker (Larimichthys crocea) that associates with MyD88 but impairs NF-κB activation.
    Zou PF; Huang XN; Yao CL; Sun QX; Li Y; Zhu Q; Yu ZX; Fan ZJ
    Fish Shellfish Immunol; 2017 Apr; 63():452-464. PubMed ID: 27989863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling.
    De Nardo D; Balka KR; Cardona Gloria Y; Rao VR; Latz E; Masters SL
    J Biol Chem; 2018 Sep; 293(39):15195-15207. PubMed ID: 30076215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway.
    Li C; Zienkiewicz J; Hawiger J
    J Biol Chem; 2005 Jul; 280(28):26152-9. PubMed ID: 15849357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two human MYD88 variants, S34Y and R98C, interfere with MyD88-IRAK4-myddosome assembly.
    George J; Motshwene PG; Wang H; Kubarenko AV; Rautanen A; Mills TC; Hill AV; Gay NJ; Weber AN
    J Biol Chem; 2011 Jan; 286(2):1341-53. PubMed ID: 20966070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional assessment of the mutational effects of human IRAK4 and MyD88 genes.
    Yamamoto T; Tsutsumi N; Tochio H; Ohnishi H; Kubota K; Kato Z; Shirakawa M; Kondo N
    Mol Immunol; 2014 Mar; 58(1):66-76. PubMed ID: 24316379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TILRR, a novel IL-1RI co-receptor, potentiates MyD88 recruitment to control Ras-dependent amplification of NF-kappaB.
    Zhang X; Shephard F; Kim HB; Palmer IR; McHarg S; Fowler GJ; O'Neill LA; Kiss-Toth E; Qwarnstrom EE
    J Biol Chem; 2010 Mar; 285(10):7222-32. PubMed ID: 19940113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of activation of IRAK1 and IRAK4 by interleukin-1 and Toll-like receptor agonists.
    Vollmer S; Strickson S; Zhang T; Gray N; Lee KL; Rao VR; Cohen P
    Biochem J; 2017 Jun; 474(12):2027-2038. PubMed ID: 28512203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways.
    Pereira M; Durso DF; Bryant CE; Kurt-Jones EA; Silverman N; Golenbock DT; Gazzinelli RT
    Cell Rep; 2022 Aug; 40(7):111225. PubMed ID: 35977521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both IRAK3 and IRAK1 Activate the MyD88-TRAF6 Pathway in Zebrafish.
    Weng P; Lan M; Zhang H; Fan H; Wang X; Ran C; Yue Z; Hu J; Xu A; Huang S
    J Immunol; 2024 Aug; 213(3):362-372. PubMed ID: 38847613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MyD88 Death-Domain Oligomerization Determines Myddosome Architecture: Implications for Toll-like Receptor Signaling.
    Moncrieffe MC; Bollschweiler D; Li B; Penczek PA; Hopkins L; Bryant CE; Klenerman D; Gay NJ
    Structure; 2020 Mar; 28(3):281-289.e3. PubMed ID: 31995744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A noncanonical IRAK4-IRAK1 pathway counters DNA damage-induced apoptosis independently of TLR/IL-1R signaling.
    Li Y; Shah RB; Sarti S; Belcher AL; Lee BJ; Gorbatenko A; Nemati F; Yu H; Stanley Z; Rahman M; Shao Z; Silva JM; Zha S; Sidi S
    Sci Signal; 2023 Dec; 16(816):eadh3449. PubMed ID: 38113335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.